AnaptysBio, Inc. (ANAB) came out with a quarterly loss of $1.14 per share versus the Zacks Consensus Estimate of a loss of $1.72. This compares to loss of $1.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 33.72%. A quarter ago, it was expected that this company would post a loss of $1.20 per share when it actually produced a loss of $1.71, delivering a surprise of -42.50%.Over the last four quarters, the company has surpas ...